Demonstration of burst-promoting activity of recombinant human GM-CSF on circulating erythroid progenitors using an assay involving the delayed addition of erythropoietin

Blood. 1985 Dec;66(6):1479-81.

Abstract

We demonstrate through the use of an in vitro assay involving the delayed addition of erythropoietin that human recombinant GM-CSF, cloned from a mature T cell line, Mo, clearly has burst-promoting activity (BPA) on peripheral blood erythroid progenitors at picomolar concentrations. Delay for up to 72 hours of the addition of erythropoietin to semi-solid methylcellulose cultures of concentrated peripheral blood progenitors minimizes or eliminates BPA-independent erythroid colony formation with little loss of BPA-dependent erythroid colony formation. This assay will prove useful in accurately detecting sources of BPA.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Differentiation / drug effects
  • Cells, Cultured
  • Colony-Stimulating Factors / pharmacology*
  • Erythropoiesis / drug effects*
  • Erythropoietin / pharmacology
  • Hematopoietic Stem Cells / drug effects
  • Humans
  • Methods
  • Recombinant Proteins / pharmacology*
  • Time Factors

Substances

  • Colony-Stimulating Factors
  • Recombinant Proteins
  • Erythropoietin